FDA issued a Warning Letter to Ropack, Inc. on 8/3/2016 as a result of this inspection.
FDA investigators audited the Ropack - Anjou, Canada facility and issued inspectional observations (via FDA 483) on 21 Jan 2016.
Add To Cart
- Category: Human Drugs / Medical Devices & Rad Health
- Inspection end: 21 Jan 2016
- Location: Anjou, Canada
- FEI: 3002674295